Screener
Nutex Health Inc. NUTX Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$210.8MMiss by $4.3M
EPS$9.38Beat by $4.43
Revenue estimate$215.0M
EPS estimate$4.95
“2026 is continuing to be a solid financial year, including total revenue of $427.2 million, net income attributable to Nutex of $112.6 million, diluted EPS of $15.87 per share and $109.7 million of operating cash flow in the first six months of 2026. We also delivered meaningful operating income improvement, with operating income increasing to $203.0 million for the first six months of 2026 from $114.3 million in the same period of 2025, supported by lower total operating costs and expenses of $194.2 million compared to $212.5 million in the prior-year period. Our balance sheet remains strong with a cash balance of $205.2 million and long-term debt of $31.1 million. We believe we are set up well for finishing the year strong as we continue to grow with the expected opening of three new hospital later this year.”
Next report
Nov 17, 2026 (in 2 months)Revenue estimate$215.0M
EPS estimate$5.71
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Nutex Health Inc. report Q2 2026 earnings?
- Nutex Health Inc. (NUTX) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Nutex Health Inc.'s Q2 2026 revenue and EPS?
- Nutex Health Inc. reported revenue of $210.8M and eps of $9.38 for Q2 2026.
- Did Nutex Health Inc. beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $215.0M by $4.3M. EPS beat the consensus estimate of $4.95 by $4.43.
- How did Nutex Health Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 13.6% from $244.0M a year earlier.
- Where can I find Nutex Health Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-054274) and the 10-Q periodic report (0001628280-26-054268) directly on SEC EDGAR. The filing index links above go to sec.gov.
